Organization Overview
Alternative names
acetaminophen (tylenol) (6 trials)
acetylsalicylic acid (aspirin) (6 trials)
aciclovir (zovirax) (14 trials)
adefovir dipivoxil (hepsera) (1 trial)
albendazole (Albenza) (4 trials)
alirocumab (praluent) (1 trial)
amitriptyline (elavil) (5 trials)
anastrozole (arimidex) (5 trials)
atorvastatin (lipitor) (5 trials)
azithromycin (zithromax) (12 trials)
baloxavir marboxil (xofluza) (1 trial)
benzoyl peroxide (clearasil) (1 trial)
beta carotene (solatene) (1 trial)
betamethasone (celestone) (1 trial)
chlorhexidine (hibitane) (5 trials)
cobicistat (stribild) (2 trials)
colesevelam (welchol) (2 trials)
conjugated equine estrogens (4 trials)
dapagliflozin (farxiga) (1 trial)
desogestrel (Mercilon) (2 trials)
dextromethorphan (delsym) (1 trial)
doxycycline (vibramycin) (5 trials)
dronabinol (marinol) (1 trial)
dutasteride (avodart) (7 trials)
efavirenz (sustiva) (3 trials)
elvitegravir (vitekta) (1 trial)
emtricitabine (emtriva) (14 trials)
escitalopram (lexapro) (2 trials)
estradiol (progynon depot) (7 trials)
etanercept (enbrel) (6 trials)
ethinyl estradiol (Estinyl) (4 trials)
exemestane (aromasin) (4 trials)
fluoxetine (prozac) (4 trials)
gadobutrol (gadavist) (1 trial)
gadoteric acid (Dotarem) (2 trials)
galantamine (reminyl) (1 trial)
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (4 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (3 trials)
human rotavirus, live attenuated (Rotarix) (1 trial)
hydroxyzine (vistaril) (1 trial)
hypericum perforatum (1 trial)
insulin degludec (tresiba) (1 trial)
insulin glargine (toujeo) (2 trials)
insulin human (humulin) (4 trials)
interferon alpha-2b (Intron-A) (7 trials)
irradiated donor lymphocyte (1 trial)
isotretinoin (accutane) (3 trials)
leukoreduced blood components (1 trial)
levobupivacaine (chirocaine) (4 trials)
lidocaine (xylocaine) (6 trials)
lisdexamfetamine (vyvanse) (2 trials)
live attenuated varicella vaccine (1 trial)
medroxyprogesterone (provera) (6 trials)
meperidine (demerol) (2 trials)
methadone (methadose) (3 trials)
methylphenidate (ritalin) (4 trials)
mifepristone (mifeprex) (1 trial)
modafinil (provigil) (1 trial)
naltrexone (revia) (45 trials)
naproxen (naprosyn) (3 trials)
nateglinide (starlix) (1 trial)
neostigmine (bloxiverz) (1 trial)
oxycodone (oxycontin) (5 trials)
paclitaxel (taxol) (26 trials)
perflutren protein-type a microspheres (Optison) (1 trial)
phentolamine mesylate (regitine) (1 trial)
pioglitazone (actos) (1 trial)
pravastatin (pravachol) (4 trials)
procaine benzylpenicillin (novocaine) (4 trials)
progesterone (progestasert) (4 trials)
quetiapine (seroquel) (2 trials)
raltegravir (isentress) (5 trials)
rimabotulinumtoxinB (Myobloc) (3 trials)
rocuronium (zemuron) (3 trials)
ropivacaine (naropin) (2 trials)
rosuvastatin (crestor) (3 trials)
sertraline (zoloft) (4 trials)
sildenafil (viagra) (2 trials)
simvastatin (zocor) (7 trials)
sirolimus (rapamune) (16 trials)
sitagliptin (januvia) (5 trials)
solifenacin (vesicare) (1 trial)
succinylcholine (anectine) (1 trial)
sugammadex (bridion) (2 trials)
tacrolimus (prograf) (36 trials)
tamoxifen (nolvadex) (6 trials)
tenofovir (viread) (26 trials)
testosterone (delatestryl) (24 trials)
tobramycin (nebcin) (5 trials)
tolterodine (detrol) (2 trials)
toremifene (fareston) (1 trial)
triamcinolone (kenalog) (4 trials)
valaciclovir (Valtrex) (11 trials)
valganciclovir (valcyte) (4 trials)
varicella zoster virus glycoprotein e antigen (Shingrix) (1 trial)
vecuronium (norcuron) (1 trial)
abatacept (orencia) (2 trials)
acetazolamide (diamox) (1 trial)
acetylcysteine (mucomyst) (6 trials)
aldesleukin (proleukin) (37 trials)
allogeneic hematopoietic stem cells (Hemacord) (73 trials)
allopurinol (zyloprim) (3 trials)
alteplase (Activase) (4 trials)
ambrisentan (letairis) (1 trial)
amiodarone (cordarone) (3 trials)
amphetamine (Adderall) (1 trial)
amprenavir (agenerase) (1 trial)
autologous hematopoietic cell (15 trials)
autologous mesenchymal stem cells (1 trial)
autologous mononuclear stem cell (2 trials)
avelumab (bavencio) (3 trials)
aztreonam (azactam) (2 trials)
beclomethasone (vanceril) (3 trials)
bicalutamide (casodex) (4 trials)
bortezomib (velcade) (9 trials)
bupropion (wellbutrin) (2 trials)
busulfan (myleran) (34 trials)
carboplatin (paraplatin) (24 trials)
carmustine (bicnu) (14 trials)
celecoxib (celebrex) (2 trials)
cholestyramine (questran) (1 trial)
cisplatin (platinol) (18 trials)
colestipol (colestid) (1 trial)
cyclophosphamide (cytoxan) (119 trials)
dacarbazine (dtic-dome) (3 trials)
dactinomycin (cosmegen) (1 trial)
dalfampridine (ampyra) (1 trial)
daunorubicin (cerubidine) (7 trials)
dexmethylphenidate (focalin) (1 trial)
docetaxel (taxotere) (19 trials)
doxorubicin (Doxil) (31 trials)
eculizumab (Soliris) (1 trial)
epinephrine (levophed) (1 trial)
ethambutol (myambutol) (1 trial)
etoposide (vepesid) (41 trials)
filgrastim (neupogen) (14 trials)
flecainide (tambocor) (1 trial)
fluconazole (diflucan) (4 trials)
fludarabine (fludara) (106 trials)
fluorouracil (efudex) (2 trials)
flutamide (eulexin) (3 trials)
gabapentin (neurontin) (1 trial)
gadopenteate dimeglumine (magnevist) (2 trials)
ganciclovir (cytovene) (4 trials)
gemtuzumab ozogamicin (mylotarg) (8 trials)
gentamicin (garamycin) (2 trials)
goserelin (zoladex) (8 trials)
hydrocortisone (solu-cortef) (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
ibandronate (boniva) (2 trials)
imipramine (tofranil) (1 trial)
inactivated influenza vaccine (5 trials)
isoniazid (nydrazid) (4 trials)
itraconazole (sporanox) (2 trials)
ivacaftor (Kalydeco) (2 trials)
lactobacillus crispatus (1 trial)
lenalidomide (revlimid) (6 trials)
leuprolide (lupron) (9 trials)
liothyronine (cytomel) (3 trials)
lopinavir (Kaletra) (7 trials)
lovastatin (mevacor) (2 trials)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (1 trial)
magnesium sulfate (Tis-U-Sol) (1 trial)
melphalan (alkeran) (35 trials)
metformin (glucophage) (1 trial)
methylprednisolone (medrol) (8 trials)
metoclopramide (reglan) (2 trials)
metronidazole (flagyl) (3 trials)
mexiletine (mexitil) (3 trials)
minocycline (minocin) (3 trials)
moricizine (ethmozine) (1 trial)
mycophenolate (myfortic) (84 trials)
nelfinavir (viracept) (3 trials)
nevirapine (viramune) (5 trials)
nilutamide (nilandron) (1 trial)
nitric oxide (inomax) (2 trials)
nitroglycerin (transderm-nitro) (1 trial)
palivizumab (Synagis) (1 trial)
pancrelipase (creon) (1 trial)
pentoxifylline (trental) (1 trial)
peripheral blood hematopoietic cell (93 trials)
procainamide (pronestyl) (1 trial)
propafenone (rythmol) (1 trial)
rifapentine (priftin) (2 trials)
rituximab (rituxan) (41 trials)
saquinavir (invirase) (2 trials)
sargramostim (leukine) (69 trials)
secretin human (chirhostim) (1 trial)
streptokinase (streptase) (1 trial)
sulfamethoxazole (gantanol) (4 trials)
tenofovir alafenamide (genvoya) (1 trial)
thalidomide (Thalomid) (5 trials)
tositumomab (bexxar) (5 trials)
tranexamic acid (cyklokapron) (3 trials)
trazodone (desyrel) (2 trials)
triptorelin (Trelstar) (2 trials)
ursodeoxycholic acid (1 trial)
valproic acid (depakene) (1 trial)
vinblastine (velban) (5 trials)
vincristine (oncovin) (19 trials)
vinorelbine (navelbine) (9 trials)
abemaciclib (verzenio) (1 trial)
abiraterone (zytiga) (5 trials)
acalabrutinib (calquence) (4 trials)
adeno-associated viral with human factor ix (1 trial)
albumin (Human) (Plasbumin) (1 trial)
alemtuzumab (campath) (6 trials)
allogeneic cytomegalovirus-specific cytotoxic t lymphocytes (1 trial)
allogeneic lymphocytes (18 trials)
allogeneic natural killer cells (2 trials)
alpha-1 antitrypsin (Prolastin) (1 trial)
amantadine (symmetrel) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (23 trials)
apalutamide (erleada) (2 trials)
arsenic trioxide (trisenox) (1 trial)
asparaginase (elspar) (2 trials)
atezolizumab (tecentriq) (4 trials)
autologous-allogeneic tandem hematopoietic stem cell (2 trials)
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes (2 trials)
autologous bone marrow (3 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (2 trials)
autologous cd34+ cells (1 trial)
autologous lymphocytes (14 trials)
autologous platelets (1 trial)
autologous umbilical cord blood (6 trials)
autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes (2 trials)
axicabtagene ciloleucel (Yescarta) (2 trials)
azacitidine (vidaza) (5 trials)
bacille calmette-guerin (2 trials)
baricitinib (olumiant) (1 trial)
belinostat (beleodaq) (1 trial)
bendamustine (treanda) (6 trials)
beractant (survanta) (2 trials)
bevacizumab (avastin) (9 trials)
bleomycin (blenoxane) (1 trial)
brentuximab vedotin (adcetris) (5 trials)
cabozantinib (cometriq) (3 trials)
calcitriol (rocaltrol) (1 trial)
capecitabine (xeloda) (12 trials)
carbon dioxide (dry ice) (1 trial)
carfilzomib (kyprolis) (4 trials)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine (3 trials)
cd45-depleted allogenic peripheral blood stem cell (1 trial)
ceftriaxone (rocephin) (2 trials)
certolizumab pegol (cimzia) (1 trial)
cetuximab (erbitux) (4 trials)
ciprofloxacin (cipro) (4 trials)
citalopram (celexa) (2 trials)
cladribine (leustatin) (10 trials)
clarithromycin (biaxin) (3 trials)
clofarabine (clolar) (9 trials)
clofazimine (lamprene) (1 trial)
clonidine (catapres) (2 trials)
cytolytic t-lymphocytes (1 trial)
darbepoetin alfa (aranesp) (2 trials)
dasatinib (sprycel) (3 trials)
decitabine (dacogen) (7 trials)
deferasirox (exjade) (1 trial)
deferoxamine (desferal) (2 trials)
degarelix acetate (firmagon) (2 trials)
denileukin diftitox (ontak) (4 trials)
diethylstilbestrol (Fosfestrol) (1 trial)
dimethandrolone undecanoate (3 trials)
dolutegravir (tivicay) (1 trial)
doravirine (pifeltro) (1 trial)
durvalumab (imfinzi) (8 trials)
emicizumab (Hemlibra) (1 trial)
erlotinib (tarceva) (7 trials)
everolimus (zortress) (2 trials)
ex vivo-expanded her2-specific t cells (3 trials)
fedratinib (Inrebic) (2 trials)
ferumoxytol (feraheme) (1 trial)
finasteride (Proscar) (2 trials)
fish oil (Omegavan) (3 trials)
fludeoxyglucose f-18 (14 trials)
flumazenil (mazicon ) (1 trial)
fluticasone (cutivate) (1 trial)
gallium nitrate (ganite) (3 trials)
gemcitabine (gemzar) (10 trials)
glasdegib (Daurismo) (1 trial)
glyburide (micronase) (2 trials)
gtu-multihiv b clade (1 trial)
hemopoietic stem cell (2 trials)
her-2/neu peptide vaccine (7 trials)
human fecal microbiota (Reybota) (4 trials)
hyaluronidase (human recombinant) (hylenex) (1 trial)
hydroxyurea (hydrea) (2 trials)
ibritumomab tiuxetan (zevalin) (5 trials)
ibrutinib (imbruvica) (2 trials)
icosapent ethyl (vascepa) (4 trials)
idarubicin (idamycin) (5 trials)
idelalisib (zydelig) (1 trial)
imatinib (gleevec) (10 trials)
immune globulin (human) (1 trial)
indomethacin (indocin) (1 trial)
insulin detemir (Levemir) (1 trial)
in vitro-treated bone marrow (2 trials)
in vitro-treated peripheral blood stem cell (7 trials)
ipilimumab (yervoy) (3 trials)
irinotecan (Camptosar) (3 trials)
Isatuximab (Sarclisa) (1 trial)
ketoconazole (nizoral) (3 trials)
low molecular weight iron dextran (1 trial)
lv-nyeso tcr /sr39tk pbsc (1 trial)
macimorelin (Macrilen) (1 trial)
mage-a1-specific t cell receptor-transduced autologous t-cells (1 trial)
mcpyv tag-specific polyclonal autologous cd8-positive t cells (2 trials)
melitac 12.1 peptide vaccine (1 trial)
mercaptopurine (purinethol) (1 trial)
methylene blue (proveblue) (1 trial)
mitoxantrone (novantrone) (17 trials)
modified vaccinia ankara-5t4 vaccine (1 trial)
monoclonal antibody cd19 (1 trial)
monoclonal antibody cd20 (1 trial)
montelukast (singulair) (1 trial)
mrkad5 hiv-1 gag/pol/nef (2 trials)
muc1 dendritic cell vaccine (1 trial)
mupirocin (bactroban) (2 trials)
muromonab cd3 (Orthoclone OKT3) (1 trial)
n-(4-hydroxyphenyl)all-trans retinamide (1 trial)
nilotinib (tasigna) (2 trials)
nitrofurantoin (furadantin) (1 trial)
norelgestromin (Evra) (1 trial)
obinutuzumab (gazyva) (1 trial)
olaparib (lynparza) (5 trials)
omalizumab (xolair) (2 trials)
omeprazole (prilosec) (1 trial)
ondansetron (zofran) (4 trials)
oprelvekin (Neumega) (1 trial)
oseltamivir (tamiflu) (1 trial)
oxaliplatin (eloxatin) (3 trials)
p52-/p36- gap vaccine (1 trial)
panobinostat (farydak) (2 trials)
parathyroid hormone (Natpara) (1 trial)
paricalcitol (zemplar) (1 trial)
patient derived cd19 specific car t cells also expressing an egfrt (1 trial)
pazopanib (votrient) (3 trials)
peginterferon beta-1a (Plegridy) (2 trials)
pembrolizumab (keytruda) (18 trials)
pemetrexed (alimta) (2 trials)
pentostatin (nipent) (1 trial)
peripheral blood lymphocytes (1 trial)
pertuzumab (perjeta) (2 trials)
pexidartinib (Turallo) (1 trial)
plerixafor (mozobil) (9 trials)
polatuzumab vedotin (Polivy) (2 trials)
polyethylene glycol 3350 (colyte) (1 trial)
pomalidomide (pomalyst) (1 trial)
procarbazine (matulane) (1 trial)
pumvc3-igfbp2-her2-igf1r plasmid dna vaccine (1 trial)
pyridostigmine bromide (mestinon) (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (2 trials)
rifaximin (xifaxan) (2 trials)
rilpivirine (edurant) (2 trials)
risperidone (risperdal) (1 trial)
ruxolitinib (jakafi) (4 trials)
sacituzumab govitecan (1 trial)
sodium tetradecyl sulfate (sotradecol) (1 trial)
sorafenib (nexavar) (6 trials)
spironolactone (aldactone) (1 trial)
sumatriptan (zecuity) (1 trial)
synthetic tumor-associated peptide vaccine therapy (1 trial)
temozolomide (temodar) (5 trials)
tesamorelin (egrifta) (1 trial)
thrombin (bovine) (Thrombostat) (1 trial)
tocilizumab (actemra) (1 trial)
topotecan (hycamtin) (6 trials)
trabectedin (yondelis) (3 trials)
trastuzumab (herceptin) (9 trials)
tumour infiltrating lymphocytes (3 trials)
ustekinumab (stelara) (1 trial)
valerian root extract (1 trial)
venetoclax (venclexta) (2 trials)
vorinostat (zolinza) (13 trials)
vrc-hivdna009-00-vp (2 trials)
vrc-hivmab060-00-ab (3 trials)
vrc-hivmab080-00-ab (2 trials)
vrc-malmab0100-00-ab (1 trial)
wt1-sensitized allogeneic t-lymphocytes (1 trial)
11betamethyl nortestosterone dodecylcarbonate (2 trials)
4-1bbζ b7h3-egfrt-dhfr (1 trial)
4-1bbζ egfr806-egfrt (1 trial)
allogeneic cord blood (2 trials)
alpha-tocopheryloxyacetic acid (1 trial)
aluminum hydroxide (Gaviscon) (2 trials)
aminolevulinic acid (levulan) (1 trial)
anti-cd20 b9e9 scfv-streptavidin fusion protein (1 trial)
autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 (1 trial)
autologous cd19 car+ egftt + t cells (1 trial)
autologous immunoglobulin idiotype-klh conjugate vaccine (1 trial)
autologous mesothelin-specific tcr-t cells (1 trial)
autologous ny-eso-1-specific cd8-positive t lymphocytes (2 trials)
bg505 sosip.664 gp140 (2 trials)
bimatoprost (lumigan) (1 trial)
c46/ccr5/p140k lentiviral vector-transduced autologous hspcs (1 trial)
calcipotriene (dovonex) (1 trial)
cd22-specific car t-cells also expressing an egfrt (1 trial)
conivaptan (vaprisol) (1 trial)
core-g28v2 60mer mrna vaccine (1 trial)
dabigatran (pradaxa) (1 trial)
dexmedetomidine (precedex) (2 trials)
elotuzumab (empliciti) (1 trial)
enzalutamide (xtandi) (2 trials)
genetically engineered hematopoietic stem cells (1 trial)
genetically engineered lymphocyte therapy (1 trial)
humnc2-car44 car t cells (1 trial)
in111 anti-cd45 monoclonal antibody bc8 (2 trials)
inotuzumab ozogamicin (besponsa) (1 trial)
interferon gamma-1b (actimmune) (2 trials)
iodixanol (visipaque) (1 trial)
lactobacillus delbrueckii (1 trial)
lisocabtagene maraleucel (1 trial)
lvsh5/c46 (cal-1) transduced cd34+ hematopoietic stem cells (1 trial)
midostaurin (rydapt) (1 trial)
niclosamide (nicloside) (1 trial)
nortriptyline (aventyl) (1 trial)
patient derived cd171 specific car t cells expressing egfrt (1 trial)
pentazocine (talwin) (1 trial)
pirfenidone (esbriet) (1 trial)
prednisolone (hydeltra) (1 trial)
pumvc3-igfbp2-her2-igf1r (1 trial)
rabeprazole (pariet) (2 trials)
ror1 car-specific autologous t-lymphocytes (1 trial)
tagraxofusp-erzs (elzonris) (1 trial)
t-cell antigen presenting cells expressing truncated cd19 (1 trial)
trastuzumab emtansine (kadcyla) (1 trial)
vinyl alcohol polymer (1 trial)
vrc-hivdna-016-00-vp (1 trial)
alfentanil (alfenta) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
bupivacaine (Exparel) (1 trial)
cefpodoxime (vantin) (1 trial)
ceftazidime (fortaz) (2 trials)
cefuroxime (zinacef) (1 trial)
clavulanate (Augmentin) (2 trials)
darunavir (prezista) (1 trial)
desflurane (suprane) (1 trial)
dexlansoprazole (dexilant) (1 trial)
dornase alfa (pulmozyme) (1 trial)
droperidol (innovar) (1 trial)
fosamprenavir (lexiva) (1 trial)
fosfomycin (monurol) (1 trial)
glipizide (glucotrol) (1 trial)
granisetron (kytril) (1 trial)
haloperidol (haldol) (1 trial)
hydrocodone (hycodan) (1 trial)
hydromorphone (diladid) (1 trial)
insulin glulisine (Apidra) (1 trial)
linagliptin (tradjenta) (1 trial)
meclizine (antivert) (1 trial)
mirtazapine (remeron) (1 trial)
moxifloxacin (avelox) (1 trial)
nitisinone (orfadin) (1 trial)
olanzapine (zyprexa) (1 trial)
oxytocin (syntocinon) (1 trial)
palifermin (kepivance) (1 trial)
palonosetron (aloxi) (2 trials)
pamidronate (aredia) (1 trial)
piperacillin (pipracil) (1 trial)